Adirondack Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Adirondack Trust Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-105	Closed	-$13.6K	–	472
2023 Q1	$13.6K	Hold	105	–	–	0.01%	305
2022 Q4	$13.8K	Hold	105	–	–	0.01%	296
2022 Q3	$12K	Hold	105	–	–	0.01%	304
2022 Q2	$12K	Hold	105	–	–	0.01%	293
2022 Q1	$14K	Buy	+105	New	+$13.7K	0.01%	285
2018 Q4	–	Sell	-45	Closed	-$5K	–	357
2018 Q3	$5K	Buy	+45	New	+$5.3K	﹤0.01%	299
2017 Q2	–	Sell	-684	Closed	-$67K	–	325
2017 Q1	$67K	Hold	684	–	–	0.05%	146
2016 Q4	$61K	Sell	684 -240	-26%	-$21.8K	0.04%	151
2016 Q3	$89K	Buy	924 +240	+35%	+$22.8K	0.06%	134
2016 Q2	$59K	Hold	684	–	–	0.04%	166
2016 Q1	$59K	Hold	684	–	–	0.04%	148
2015 Q4	$61K	Buy	+684	New	+$74.2K	0.05%	140

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Adirondack Trust Company's IBB Position: Q2 2023 in Review

Adirondack Trust Company sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 105 shares — an estimated $13.6K sold.

Adirondack Trust Company first reported a position in IBB in Q4 2015 and held it in 12 quarters. The position peaked at $89K in Q3 2016. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Adirondack Trust Company reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
Adirondack Trust Company sold 105 iShares Biotechnology ETF shares in Q2 2023, an estimated $13.6K.
Adirondack Trust Company first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 12 quarters.
Adirondack Trust Company's iShares Biotechnology ETF position peaked at $89K in Q3 2016.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Adirondack Trust Company's 13F filing for Q2 2023, filed 9 Aug 2023.